BIZTRAC BETA
Research and experimental development on natural sciences and engineering

XELLIA PHARMACEUTICALS AS

Org. no. 971135123 Limited company (AS) Oslo Incorporated 1994 Active
Ownership graph ↗
Revenue 2024 NOK 83.1m
Operating profit NOK 7.3m
Equity NOK 707.2m
Incorporated 1994
Employees 30
Share capital NOK 223.3m

Signals

1 flags
  • Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.

XELLIA PHARMACEUTICALS AS is registered as a limited company in Oslo, Oslo with organisation number 971135123. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 1994 and has 30 registered employees. Registered share capital is NOK 223.3m, divided into 19230770 shares. The company's stated purpose is: “Utvikling, tilberedning og forhandling av farmasøytiske aktivstoffer, ferdig legemidler og dyrehelsepreparater og andre produkter i den utstrekning styret bestemmer, samt deltagelse som aksjonær, lånegiver, garantist eller på annen måte i andre foretagender.”. The most recent filed accounts, for the 2024 financial year, show NOK 83.1m in revenue and NOK 7.3m in operating profit.

Key figures · 2024

Revenue
NOK 83.1m
Operating profit
NOK 7.3m
Equity
NOK 707.2m
Est. value
NOK 411.8m

Financial health · 2024

Liquidity
3.68
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
90.5%
Very good
Equity as a share of total capital

Who owns XELLIA PHARMACEUTICALS AS?

XELLIA GROUP AS
XELLIA PHARMACEUTICALS AS
NOK 83.1m rev. · NOK 7.3m profit

XELLIA PHARMACEUTICALS AS has 1 registered shareholder:

All shareholders and roles →

Group structure

XELLIA PHARMACEUTICALS AS er morselskap for 1 datterselskap:

Frequently asked questions about XELLIA PHARMACEUTICALS AS

Who owns XELLIA PHARMACEUTICALS AS?

XELLIA GROUP AS is the largest registered owner, with 100.0%.

What is the revenue of XELLIA PHARMACEUTICALS AS?

XELLIA PHARMACEUTICALS AS had revenue of NOK 83.1m in 2024.

Who is the general manager of XELLIA PHARMACEUTICALS AS?

Michael Kocher is registered as general manager of XELLIA PHARMACEUTICALS AS.

Where is XELLIA PHARMACEUTICALS AS based?

XELLIA PHARMACEUTICALS AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.